Journal of Acupuncture Research

Korean Acupuncture & Moxibustion Medicine Society (대한침구의학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Snake Venom Toxin on Inhibition of Colorectal Cancer HT29 Cells Growth via Death Receptors Mediated Apoptosis

  • Shim, Yoon Seop (Department of Acupuncture & Moxibustion Medicine, College of Orinetal Medicine, Gachon University) ;
  • Song, Ho Sueb (Department of Acupuncture & Moxibustion Medicine, College of Orinetal Medicine, Gachon University)
  • Received : 2014.05.14
  • Accepted : 2014.05.22
  • Published : 2014.06.20
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : We investigated whether snake venom toxin(SVT) from Vipera lebetina turanica sensitizes HT29 human epithelial colorectal cancer cells to tumor necrosis factor(TNF)-related apoptosis-inducing ligand(TRAIL) induced apoptosis in cancer cells. Methods : Cell viability assay was used to assess the inhibitory effect of TRAIL on cell growth of HT29 human colorectal cancer cells. And 6-diamidino-2-phenylindole(DAPI), terminal deoxynucleotidyl transferase mediated dUTP nick end labeling assay(TUNEL) staining assay were used to evaluate cell-apoptosis. Western blot analysis were conducted to observe apoptosis related proteins and death receptor. To assess whether the synergized inhibitory effect of SVT and TRAIL on reactive oxygen species(ROS) generation was reversed by strong anti-oxidative agent. Results : SVT with TRAIL inhibited HT29 cell growth different from TRAIL alone. Consistent with cell growth inhibition, the expression of TRAIL receptors; Expression of death receptor(DR)4 and DR5 was significantly increased and intrinsic pro-apoptotic cleaved caspase-3, -9 was subsequently increased together with increase of Bax/Bcl-2 ratio and extrinsic pro-apototic caspase-8 was also activated. In addition, the expression of anti-apoptotic survival proteins, a marker of TRAIL resistance(eg, cFLIP, survivin, X-linked inhibitor of apoptosis protein(XIAP) and Bcl-2) was suppressed by the combination treatment of SVT and TRAIL. Pretreatment with the ROS scavenger N-acetylcysteine abolished the SVT and TRAIL-induced upregulation of DR4 and DR5 expression and expression of the intrinsic pro-apoptotic caspase-3 and-9. Conclusion : The collective results suggest that SVT facilitates TRAIL-induced apoptosis in $HT_{29}$ human epithelial colorectal cancer cells through up-regulation of the TRAIL receptors; DR4 and DR5 and consecutive induction of bilateral apoptosis via regulating apoptosis related proteins.

Keywords

References

  1. Yu Z, Li W. Induction of apoptosis by puerarin in colorectal cancer HT29 cells. Cancer Lett. 2006 ; 238(1) : 53-60. https://doi.org/10.1016/j.canlet.2005.06.022
  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 ; 61(2) : 69-90. https://doi.org/10.3322/caac.20107
  3. Tomida A, Tsuruo T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des. 1999 ; 14(2) : 169-77.
  4. Goldberg RM, Sargent DJ, Morton RF et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004 ; 22(1) : 23-30.
  5. Kamb A, Wee S, Lengauer C. Why is cancer drug discovery so difficult? Nature Rev Drug Discovery. 2007 ; 6(2) : 115-20. https://doi.org/10.1038/nrd2155
  6. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annual Rev Med. 2007 ; 58(1) : 267-84. https://doi.org/10.1146/annurev.med.58.062105.204854
  7. de Santa Barbara P, van den Brink GR, Roberts DJ. Development and differentiation of the intestinal epithelium. Cell Mol Life Sci. 2003 ; 60(7) : 1322-32. https://doi.org/10.1007/s00018-003-2289-3
  8. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol. 2004 ; 4(12) : 953-64. https://doi.org/10.1038/nri1499
  9. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008 ; 8(6) : 458-66. https://doi.org/10.1038/nri2340
  10. van den Brink GR, Hardwick JC. Hedgehog interaction in colorectal cancer. Gut. 2006 ; 55(7) : 912-4. https://doi.org/10.1136/gut.2005.085902
  11. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev. 2003 ; 17(20) : 2481-95. https://doi.org/10.1101/gad.1126903
  12. Shi Y. Mechanical aspects of apoptosome assembly. Curr Opin Cell Biol. 2006 ; 18(6) : 677-84. https://doi.org/10.1016/j.ceb.2006.09.006
  13. Koschny R, Walczak H, Ganten TM. The promise of TRAIL. Potential and risks of a novel anticancer therapy. J Mol Med. 2007 ; 85(9) : 923-35. https://doi.org/10.1007/s00109-007-0194-1
  14. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer. 2008 ; 8(10) : 782-98. https://doi.org/10.1038/nrc2465
  15. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998 ; 281(5381) : 1305-8. https://doi.org/10.1126/science.281.5381.1305
  16. Wajant H, Gerspach J, Pfizenmaier K, Tumor therapeutics by design: targeting and activation of death receptors. Cytokine Growth Factor Rev. 2005 ; 16(1) : 55-76. https://doi.org/10.1016/j.cytogfr.2004.12.001
  17. Sprick MR, Weigand MA, Rieser E, et al. FADD/ MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity. 2000 ; 12(6) : 599-609. https://doi.org/10.1016/S1074-7613(00)80211-3
  18. Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998 ; 17(6) : 1675-87. https://doi.org/10.1093/emboj/17.6.1675
  19. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998 ; 94(4) : 481-90. https://doi.org/10.1016/S0092-8674(00)81589-5
  20. Chai J, Du C, Wu JW, et al. Structural and biochemical basis of apoptotic activation by Smac/ DIABLO. Nature. 2000 ; 406(6798) : 855-62. https://doi.org/10.1038/35022514
  21. Wei MC, Zong WX, Cheng EH et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001 ; 292(5517) : 727-30. https://doi.org/10.1126/science.1059108
  22. Prasad S, Yadav VR, Kannappan R, Aggarwal BB. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-indepen dent upregulation of death receptors. Evidence for the role of reactive oxygen species and JNK. J Biol Chem. 2001 ; 286(7) : 5546-57.
  23. Prasad S, Yadav VR, Ravindran J, Aggarwal BB. Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated upregulation of death receptors and down-regulation of survival proteins. Br J Pharmacol. 2012 ; 165(3) : 741-53 https://doi.org/10.1111/j.1476-5381.2011.01603.x
  24. Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colorectal cancer cells to TRAIL. J Biol Chem. 2010 ; 285(46) : 35418-27. https://doi.org/10.1074/jbc.M110.172767
  25. Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)- induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5(DR5). Carcinogenesis. 2005 ; 26(11) : 1905-13. https://doi.org/10.1093/carcin/bgi167
  26. Taniguchi H, Yoshida T, Horinaka M et al. Baicalein overcomes tumor necrosis factor- related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res. 2008 ; 68(21) : 8918-27. https://doi.org/10.1158/0008-5472.CAN-08-1120
  27. Su RY, Chi KH, Huang DY, Tai MH, Lin WW. 15 - deoxy-Delta12, 14-prostaglandin J2 up- regulates death receptor 5 gene expression in HCT116 cells: Involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. Mol Cancer Ther. 2008 ; 7(10) : 3429-40. https://doi.org/10.1158/1535-7163.MCT-08-0498
  28. Bin L, Thorburn J, Thomas LR, Clark PE, Humphreys R, Thorburn A. Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding. J Biol Chem. 2007 ; 282(38) : 28189-94. https://doi.org/10.1074/jbc.M704210200
  29. Lee SH, Shin MS, Kim HS et al. Somatic mutations of TRAIL-receptor 1 and TRAIL- receptor 2 genes in non-Hodgkin's lymphoma. Oncogene. 2001 ; 20(3) : 399-403. https://doi.org/10.1038/sj.onc.1204103
  30. Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res. 1999 ; 59(3) : 734-41.
  31. Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT. Anticancer agents sensitize tumor cells to tumor necrosis factorrelated apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res. 2001 ; 61(4) : 1645-51.
  32. Son DJ, Park MH, Chae SJ et al. Inhibitory effect of SVT from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: Induction of apoptosis through inactivation of nuclear factor kappaB. Mol Cancer Ther. 2007 ; 6(2) : 675-83.
  33. Park MH, Son DJ, Kwak DH et al. Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch Pharm Res. 2009 ; 32(11) : 1545-54. https://doi.org/10.1007/s12272-009-2106-0
  34. Oh MG, Song HS. Inhibitory effect of snake venom on colon cancer cell growth through induction of death receptor dependent apoptosis. J of Korean Acupuncture & Moxibustion Medicine Society. 2012 ; 29(1) : 25-35.
  35. Rauert H, Stuhmer T, Bargou R, Wajant H, Siegmund D. TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis. 2011 ; 2(1) : e194. https://doi.org/10.1038/cddis.2011.78
  36. Yadav VR, Prasad S, Aggarwal BB. Cardamonin sensitizes tumor cells to TRAIL through ROSand CHOP-mediated upregulation of death receptors and downregulation of survival proteins. Br J Pharmacol. 2012 ; 165(3) : 741-53. https://doi.org/10.1111/j.1476-5381.2011.01603.x
  37. Das GC, Holiday D, Gallardo R, Haas C. Taxolinduced cell cycle arrest and apoptosis: doseresponse relationship in lung cancer cells of different wildtype p53 status and under isogenic condition. Cancer Lett. 2001 ; 165(2) : 147-53. https://doi.org/10.1016/S0304-3835(01)00404-9
  38. Debatin KM. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett. 2000 ; 111-112(1) : 41-8.
  39. Pulido MD, Parrish AR. Metal-induced apoptosis: Mechanisms. Mutat Res. 2003 ; 533(1-2) : 227-41. https://doi.org/10.1016/j.mrfmmm.2003.07.015
  40. Selimovic D, Hassan M, Haike Y, Hengge UR. Taxolinduced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. Cell Signal. 2008 ; 20(2) : 311-22. https://doi.org/10.1016/j.cellsig.2007.10.015
  41. Barbu A, Welsh N, Saldeen J. Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential($\Delta\Psi$m) in pancreatic RINm5F cells: Prevention by Bcl-2. Mol Cell Endocrinol. 2002 ; 190(1) : 75-82. https://doi.org/10.1016/S0303-7207(02)00009-6
  42. Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med. 2001 ; 7(7) : 314-9. https://doi.org/10.1016/S1471-4914(01)02026-3
  43. Li JY, Xu ZJ, Tan MY, Su WK, Gong XG. 3- (4- (Benzo[d]thiazol-2-yl) -1-phenyl-1Hpyrazol- 3-yl) phenyl acetate induced HepG2 cell apoptosis through a ROS-mediated pathway. Chem Biol Interact. 2010 ; 183(3) : 341-8. https://doi.org/10.1016/j.cbi.2009.12.008
  44. Kim H, Kim EH, Eom YW et al. Sulforaphane sensitizes tumor necrosis factor-related apoptosisinducing ligand(TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res. 2006 ; 66(3) : 1740-50. https://doi.org/10.1158/0008-5472.CAN-05-1568
  45. Kim KT, Song HS. Inhibitory effect of snake venom toxin on colorectal cancer HCT116 cells growth through induction of intrinsic or extrinsic apoptosis. Journal of Korean Acupuncture & Moxibustion Medicine Society. 2013 ; 30(1) : 43-55.
  46. Ashkenazi A, Herbst RS. To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest. 2008 ; 118(6) : 1979-90. https://doi.org/10.1172/JCI34359
  47. Eberle J, Fecker LF, Forschner T, Ulrich C, Rowert-Huber J, Stockfleth E. Apoptosis pathways as promising targets for skin cancer therapy. Br J Dermatol. 2007 ; 156(3) : 18-24. https://doi.org/10.1111/j.1365-2133.2007.07855.x
  48. Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys Acta. 2010 ; 1805(2) : 123-40.
  49. Jung YH, Heo J, Lee YL, Kwon TK, Kim YH. Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Science. 2010 ; 86(9-10) : 351-7. https://doi.org/10.1016/j.lfs.2010.01.008
  50. Earnshaw WC. Apoptosis. A cellular poison cupboard. Nature. 1999 ; 397(6718) : 387-9. https://doi.org/10.1038/17015
  51. Yoneda T, Imaizumi K, Oono K et al. Activation of caspase-12, an endoplastic reticulum(ER) resident caspase, through tumor necrosis factor receptorassociated factor 2-dependent mechanism in response to the ER stress. J Biol Chem. 2001 ; 276(17) : 13935-40.
  52. Zhang L, Xing D, Chen M. Bim(L) displacing Bclx( L) promotes Bax translocation during TNFalphainduced apoptosis. Apoptosis. 2008 ; 13(7) : 950-8. https://doi.org/10.1007/s10495-008-0226-5
  53. Cohen GM. Caspases. The executioners of apoptosis. Biochem J. 1997 ; 326(pt 1) : 1-16.
  54. Chai WS, Zhu XM, Li SH, Fan JX, Chen BY. Role of Bcl-2 family members in caspase-3/9-dependent apoptosis during Pseudomonas aeruginosa infection in U937 cells. Apoptosis. 2008 ; 13(6) : 833-43. https://doi.org/10.1007/s10495-008-0197-6
  55. Radha V, Sudhakar C, Ray P, Swarup G. Induction of cytochrome c release and apoptosis by Hck-SH3 domain-mediated signalling requires caspase-3. Apoptosis. 2002 ; 7(3) : 195-207. https://doi.org/10.1023/A:1015370512425
  56. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999 ; 6(11) : 1028-42. https://doi.org/10.1038/sj.cdd.4400598
  57. Wang S, El-Deiry WS. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003 ; 22(53) : 8628-33. https://doi.org/10.1038/sj.onc.1207232
  58. Jaattela M. Escaping cell death: Survival proteins in cancer. Exp Cell Res. 1999 ; 248(1) : 30-43. https://doi.org/10.1006/excr.1999.4455
  59. Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem Pharmacol. 2008 ; 75(10) : 1946-58. https://doi.org/10.1016/j.bcp.2008.02.016
  60. Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A. Quercetin enhances TRAILmediated apoptosis in colorectal cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther. 2007 ; 6(9) : 2591-9. https://doi.org/10.1158/1535-7163.MCT-07-0001
  61. Sung B, Park B, Yadav VR, Aggarwal BB. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J Biol Chem. 2010 ; 285(15) : 11498-507. https://doi.org/10.1074/jbc.M109.090209